ID: ALA4595113

Max Phase: Preclinical

Molecular Formula: C25H42N4O13S

Molecular Weight: 638.69

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(S(=O)(=O)OC[C@H]2O[C@H](O[C@@H]3[C@@H](O)[C@H](O[C@H]4O[C@H](CN)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](N)C[C@H]3N)[C@H](O)[C@@H](N)[C@@H]2O)cc1

Standard InChI:  InChI=1S/C25H42N4O13S/c1-9-2-4-10(5-3-9)43(36,37)38-8-14-16(30)15(29)18(32)24(40-14)41-22-11(27)6-12(28)23(21(22)35)42-25-20(34)19(33)17(31)13(7-26)39-25/h2-5,11-25,30-35H,6-8,26-29H2,1H3/t11-,12+,13-,14-,15+,16-,17-,18-,19+,20-,21-,22+,23-,24-,25-/m1/s1

Standard InChI Key:  MDSZTZZGYKJPBL-MJOPLTPXSA-N

Associated Targets(Human)

Gap junction beta-2 protein 74 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Gap junction alpha-1 protein 92 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 638.69Molecular Weight (Monoisotopic): 638.2469AlogP: -5.57#Rotatable Bonds: 9
Polar Surface Area: 305.75Molecular Species: BASEHBA: 17HBD: 10
#RO5 Violations: 3HBA (Lipinski): 17HBD (Lipinski): 14#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.05CX Basic pKa: 9.54CX LogP: -4.50CX LogD: -9.92
Aromatic Rings: 1Heavy Atoms: 43QED Weighted: 0.11Np Likeness Score: 0.87

References

1. Subedi YP,Kjellgren A,Roberts P,Montgomery H,Thackeray N,Fiori MC,Altenberg GA,Chang CT.  (2020)  Amphiphilic aminoglycosides with increased selectivity for inhibition of connexin 43 (Cx43) hemichannels.,  203  [PMID:32679454] [10.1016/j.ejmech.2020.112602]

Source